The metabolic syndrome in children and adolescents: Shifting the focus to cardiometabolic risk factor clustering

Pediatrics

Volumn 140, Issue 2, 2017, Pages

  Magge, Sheela N ^a   Goodman, Elizabeth ^b   Armstrong, Sarah C ^c   Daniels, Stephen ⁱ   Corkins, Mark ⁱ   De Ferranti, Sarah ⁱ   Golden, Neville H ⁱ   Kim, Jae H ⁱ   Schwarzenberg, Sarah Jane ⁱ   Assar, Carrie L ^d   Critch, Jeff ^e   Hubbard, Van ^f   Scanlon, Kelley ^g   Soto, Valery ^h   Burrowes, Debra ⁱ   Sills, Irene N ⁱ   Casella, Samuel J ⁱ   DeMeglio, Linda A ⁱ   Gonzalez, Jose L ⁱ   Kaplowitz, Paul B ⁱ   Lynch, Jane L ⁱ   Wintergerst, Kupper A ⁱ   Laskosz, Laura ⁱ   Bolling, Christopher F ⁱ   Muth, Natalie Digate ⁱ   Rausch, John C ⁱ   Rogers, Victoria Weeks ⁱ   Schwartz, Robert P ⁱ   Goodman, C D R Alyson ^g   Thapar, Mala ⁱ   more..

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE CHILDREN S HOSPITAL   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e Canadian Pediatric Society   (Canada)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h U S DEPARTMENT OF AGRICULTURE   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TETRAHYDROLIPSTATIN; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOMETABOLIC RISK; CLUSTER ANALYSIS; COMORBIDITY; DYSLIPIDEMIA; FATTY ACID SYNTHESIS; FLATULENCE; FOLLOW UP; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HEALTH BEHAVIOR; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPOGENESIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PEDIATRICS; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN BINDING; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDERED BREATHING; STEATORRHEA; SUGAR INTAKE; TISSUE EXPANSION; WAIST CIRCUMFERENCE; WEIGHT LOSS PROGRAM; ADOLESCENT; ADULT; CHILD; MASS SCREENING; PREVALENCE; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CLUSTER ANALYSIS; COMORBIDITY; HUMANS; MASS SCREENING; METABOLIC SYNDROME; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 85026640246     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2017-1603     Document Type: Article

References (88)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607
2. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152(10):908-911
3. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156(11):1070-1077
4. Yip J, Facchini FS, Reaven GM. Resistance to insulinmediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998;83(8):2773-2776
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438
6. Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics. 2012;129(3):557-570
7. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-1250
8. Steinberger J, Daniels SR, Eckel RH, et al; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119(4):628-647
9. Zimmet P, Alberti KG, Kaufman F, et al; IDF Consensus Group. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 2007;8(5):299-306
10. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation. 2007;115(17):2316-2322
11. Goodman E. Metabolic syndrome and the mismeasure of risk. J Adolesc Health. 2008;42(6):538-540
12. Goodman E. Pediatric metabolic syndrome: smoke and mirrors or true magic? J Pediatr. 2006;148(2):149-151
13. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821-827
14. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third National Health and Nutrition Examination Survey. Circulation. 2004;110(16):2494-2497
15. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-480
16. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Circulation. 2005;112(17):2735-2752
17. Rask-Madsen C, Kahn CR. Tissuespecific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2012;32(9):2052-2059
18. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res. 2005;36(3):232-240
19. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367-377
20. Yudkin JS. Insulin resistance and the metabolic syndrome-or the pitfalls of epidemiology. Diabetologia. 2007;50(8):1576-1586
21. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900-917
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497
24. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9(3):237-252
25. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-1062
26. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26(3):575-581
27. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145(4):445-451
28. Duncan GE, Li SM, Zhou X-H. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care. 2004;27(10):2438-2443
29. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89(1):108-113
30. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008;152(2):160-164
31. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46(10):1594-1600
32. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152(2):201-206
33. Ventura EE, Lane CJ, Weigensberg MJ, Toledo-Corral CM, Davis JN, Goran MI. Persistence of the metabolic syndrome over 3 annual visits in overweight Hispanic children: association with progressive risk for type 2 diabetes. J Pediatr. 2009;155(4):535-541
34. Gustafson J, Easter B, Keil M, et al. Instability of the diagnosis of metabolic syndrome in children. Obesity. 2007;15(suppl):A172
35. Stanley TL, Chen ML, Goodman E. The typology of metabolic syndrome in the transition to adulthood. J Clin Endocrinol Metab. 2014;99(3):1044-1052
36. Gustafson JK, Yanoff LB, Easter BD, et al. The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab. 2009;94(12):4828-4834
37. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806-814
38. Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012;308(6):591-600
39. Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169(3):272-279
40. Yu SS, Ramsey NL, Castillo DC, Ricks M, Sumner AE. Triglyceride-based screening tests fail to recognize cardiometabolic disease in African immigrant and African-American men. Metab Syndr Relat Disord. 2013;11(1):15-20
41. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650-1656
42. Kelly AS, Steinberger J, Jacobs DR, Hong CP, Moran A, Sinaiko AR. Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood. Int J Pediatr Obes. 2011;6(2-2): e283-e289
43. Gurka MJ, Ice CL, Sun SS, Deboer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol. 2012;11:128
44. Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation. 2005;111(15):1970-1977
45. Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA, Berenson GS. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. JAMA. 1997;278(21):1749-1754
46. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337(13):869-873
47. Fadzlina AA, Harun F, Nurul Haniza MY, et al. Metabolic syndrome among 13 year old adolescents: prevalence and risk factors. BMC Public Health. 2014;14(suppl 3):S7
48. Farber HJ, Groner J, Walley S, Nelson K; Section on Tobacco Control. Protecting children from tobacco, nicotine, and tobacco smoke. Pediatrics. 2015;136(5). Available at: www. pediatrics. org/ cgi/ content/ full/ 136/ 5/ e1439
49. Crespo CJ, Smit E, Troiano RP, Bartlett SJ, Macera CA, Andersen RE. Television watching, energy intake, and obesity in US children: results from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2001;155(3):360-365
50. Council on Communications and Media. Media and young minds. Pediatrics. 2016;138(5):e20162591
51. Council on Communications and Media. Media use in school-aged children and adolescents. Pediatrics. 2016;138(5):e20162592
52. Iglayreger HB, Peterson MD, Liu D, et al. Sleep duration predicts cardiometabolic risk in obese adolescents. J Pediatr. 2014;164(5):1085-1090.e1
53. Koren D, Levitt Katz LE, Brar PC, Gallagher PR, Berkowitz RI, Brooks LJ. Sleep architecture and glucose and insulin homeostasis in obese adolescents. Diabetes Care. 2011;34(11):2442-2447
54. Yu Y, Lu BS, Wang B, et al. Short sleep duration and adiposity in Chinese adolescents. Sleep. 2007;30(12):1688-1697
55. Ohkuma T, Fujii H, Iwase M, et al. Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care. 2013;36(3):611-617
56. Kanagasabai T, Ardern CI. Contribution of inflammation, oxidative stress, and antioxidants to the relationship between sleep duration and cardiometabolic health. Sleep. 2015;38(12):1905-1912
57. Steffen LM, Jacobs DR Jr, Murtaugh MA, et al. Whole grain intake is associated with lower body mass and greater insulin sensitivity among adolescents. Am J Epidemiol. 2003;158(3):243-250
58. Steffen LM, Jacobs DR Jr, Stevens J, Shahar E, Carithers T, Folsom AR. Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003;78(3):383-390
59. Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes. 2012;2012:1-9
60. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(suppl 4):S164-S192
61. Anderson AD, Solorzano CM, McCartney CR. Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med. 2014;32(3):202-213
62. Silverstein J, Cheng P, Ruedy KJ, et al; Pediatric Diabetes Consortium. Depressive symptoms in youth with type 1 or type 2 diabetes: results of the pediatric diabetes consortium screening assessment of depression in diabetes study. Diabetes Care. 2015;38(12):2341-2343
63. Nemiary D, Shim R, Mattox G, Holden K. The relationship between obesity and depression among adolescents. Psychiatr Ann. 2012;42(8):305-308
64. Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569-576
65. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686-692
66. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea [retracted in N Engl J Med. 2013;369(18):1770]. N Engl J Med. 2011;365(24):2277-2286
67. Steinberger J, Daniels SR; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young); American Heart Association Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107(10):1448-1453
68. Whitlock EP, O'Conner EA, Williams SB, Beil TL, Lutz KW. Effectiveness of Primary Care Interventions for Weight Management in Children and Adolescents: An Updated, Targeted Systematic Review for the USPSTF [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); 2010
69. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256
70. Levy-Marchal C, Arslanian S, Cutfield W, et al; ESPE-LWPES-ISPAD-APPESAPEG-SLEP-JSPE; Insulin Resistance in Children Consensus Conference Group. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010;95(12):5189-5198
71. American Diabetes Association. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care. 2016;39(suppl 1):S4-S5
72. Ho M, Garnett SP, Baur L, et al. Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis. Pediatrics. 2012;130(6). Available at: www. pediatrics. org/ cgi/ content/ full/ 130/ 6/ e1647
73. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol. 2006;48(9):1865-1870
74. Albala C, Ebbeling CB, Cifuentes M, Lera L, Bustos N, Ludwig DS. Effects of replacing the habitual consumption of sugar-sweetened beverages with milk in Chilean children. Am J Clin Nutr. 2008;88(3):605-611
75. Ebbeling CB, Feldman HA, Chomitz VR, et al. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med. 2012;367(15):1407-1416
76. Ebbeling CB, Feldman HA, Osganian SK, Chomitz VR, Ellenbogen SJ, Ludwig DS. Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study. Pediatrics. 2006;117(3):673-680
77. French SA, Sherwood NE, JaKa MM, Haapala JL, Ebbeling CB, Ludwig DS. Physical changes in the home environment to reduce television viewing and sugar-sweetened beverage consumption among 5-to 12-year-old children: a randomized pilot study. Pediatr Obes. 2016; 11(5):e12-e15
78. Best JR, Theim KR, Gredysa DM, et al. Behavioral economic predictors of overweight children's weight loss. J Consult Clin Psychol. 2012;80(6):1086-1096
79. Epstein LH, Roemmich JN, Robinson JL, et al. A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children. Arch Pediatr Adolesc Med. 2008;162(3):239-245
80. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403
81. Schmitz KH, Jacobs DR Jr, Hong CP, Steinberger J, Moran A, Sinaiko AR. Association of physical activity with insulin sensitivity in children. Int J Obes Relat Metab Disord. 2002;26(10):1310-1316
82. Stabelini Neto A, de Campos W, Dos Santos GC, Mazzardo Junior O. Metabolic syndrome risk score and time expended in moderate to vigorous physical activity in adolescents. BMC Pediatr. 2014;14:42
83. Yanovski SZ, Yanovski JA. Longterm drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74-86
84. McDuffie JR, Calis KA, Uwaifo GI, et al. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab. 2004;17(3): 307-319
85. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res. 2002;10(7):642-650
86. Inge TH, Courcoulas AP, Jenkins TM, et al; Teen-LABS Consortium. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374(2): 113-123
87. Park MH, Kinra S, Ward KJ, White B, Viner RM. Metformin for obesity in children and adolescents: a systematic review. Diabetes Care. 2009;32(9):1743-1745
88. Copeland KC, Silverstein J, Moore KR, et al; American Academy of Pediatrics. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics. 2013;131(2):364-382